About
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative non-invasive patient monitoring technologies, medical devices, and a wide array of sensors. Masimo SET® helps clinicians monitor 100 million patients in healthcare settings worldwide. Founded in 1989 as a private company, today, Masimo is publicly traded and employs 4,600 people worldwide, with annual revenues of $800 million. Licensing agreements allow Masimo technology to work inside monitoring devices from manufacturers including Philips, Atom, Mindray North America, GE Medical, Spacelabs, and Zoll. Masimo’s mission is to improve patient outcomes and reduce the cost of care.